Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Jan 16 2026

· Issued by Dr. Lalchandani Labs Ltd. via BSE India

Filed with BSE ·

We are pleased to inform that the company has received the In-principle approval from BSE Limited for Rights issue of Equity Shares, the letter is enclosed

View Attachment

6ix hasn’t read this filing yet.

Dr. Lalchandani Labs Ltd. on 6ix

Earlier from Dr. Lalchandani Labs

Later from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases